Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Gangat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2010- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
Aga Khan Medical CollegeClass of 2002
Certifications & Licensure
MN State Medical License 2006 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Clinical Trials
- Actuate 1901: 9-ING-41 in Myelofibrosis Start of enrollment: 2020 Aug 20
Roles: Contact
Publications & Presentations
PubMed
- Therapeutic Targeting of the Activin Receptor Signaling Pathway: Proof of Concept in Myeloid Neoplasms.Ayalew Tefferi, Naseema Gangat
American Journal of Hematology. 2025-05-01 - Venetoclax schedule in AML: 7 vs 14 vs 21 vs 28 days.Naseema Gangat, Ayalew Tefferi
Blood Cancer Journal. 2025-04-03 - 2 citationsTP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance.Ayalew Tefferi, Maymona Abdelmagid, Giuseppe G Loscocco, Saubia Fathima, Kebede H Begna
American Journal of Hematology. 2025-04-01
Journal Articles
- MPL-Mutated Essential Thrombocythemia: A Morphologic ReappraisalNaseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
- Determinants of Long-Term Outcome in Type 1 Calreticulin-Mutated MyelofibrosisNaseema Gangat, Natasha Szuber, Rhett P Ketterling, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
